Hosted on MSN8h
TD Cowen Downgrades Syros Pharmaceuticals (SYRS)Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...
Shares of Coty (NYSE:COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...
TD Cowen raised the firm’s price target on Triumph Group (TGI) to $20 from $14 and keeps a Hold rating on the shares. The firm said they reported an impressive turnaround an updated its model ...
We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...
Ginkgo Bioworks (DNA) reported strong Q3 results driven by $45M in released deferred revenues from the terminated contract with Motif, and cost ...
Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...
Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...
Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...
Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...
In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Willis Towers Watson (WTW – Research Report), with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback